Seattle Children's
This page includes a searchable index of all resources created by Seattle Children’s Hospital and University of Washington. If you would like to add a resource to this index, please contact us.
WHO Guidance for Business Continuity Planning
The WHO guidance for business continuity planning helps prepare for emergencies like pandemics. It describes how WHO can keep running during crises by identifying key …
Ask aRCie
Emergency Response Framework: Internal WHO Procedures
The Emergency Response Framework by WHO explains how the organization responds to health emergencies. It describes the steps and procedures WHO follows to manage crises …
Regional Training Package on Integrated Care for Health and Development of Newborns and Children Under Five at Home: Participant Manual
The participant manual is a regional training package focused on the health and development of newborns and children under five at home. It describes how …
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
2024
· Centers for Disease Control and Prevention (CDC),
· U.S. Public Health Service,
· University of Rochester,
· University of Cincinnati,
· Cincinnati Children's Hospital Medical Center,
· Vanderbilt University,
· Texas Children's Hospital,
· Baylor College of Medicine,
· University of Washington,
· University of Pittsburgh,
· Children's Mercy Kansas City
This study looks at the impact of respiratory syncytial virus (RSV) in young children during the 2023-2024 season. It describes how two new RSV prevention …
Potential Effects on Elderly People From Nirsevimab Use in Infants
2024
· World Health Organization (WHO),
· Instituto de Estudios de Ciencias de la Salud de Castilla y León, ICSCYL,
· Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECC),
· University of Valladolid
This article is about nirsevimab, a new treatment for infants to prevent severe RSV disease. It describes how using nirsevimab in babies might help protect …
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024
2024
· Centers for Disease Control and Prevention (CDC),
· Vanderbilt University,
· Seattle Children's Hospital,
· Baylor College of Medicine,
· University of Rochester
This study examines the effectiveness of nirsevimab, a monoclonal antibody, in preventing RSV-related hospitalizations in infants during their first RSV season. Conducted from October 2023 …
The Integration of Mental Health and Psychosocial Support and Disaster Risk Reduction: A Mapping and Review
This article is about how mental health support and disaster risk reduction (DRR) can work together. It describes efforts to combine these fields, focusing on …
Delivering Childhood Cancer Care in Fragile and Conflict Settings: Best Practices from the Occupied Palestine Territory
The article describes how childhood cancer care is provided in the occupied Palestine territory, a region facing conflict and instability. It highlights best practices used …
INSPIRE: Seven Strategies for Ending Violence Against Children
This document by the World Health Organization provides ways to stop violence against kids. It describes seven key strategies: implementing laws, changing norms and values, …
Addressing Violence Against Children, Women and Older People During the COVID-19 Pandemic: Key Actions
This report focuses on the rise in violence against children, women, and older people during the COVID-19 pandemic. It describes key actions to help protect …